- Filed
- Mar 15, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Mar 15, 2024 | 4.9M sh |
| Cash And Equivalents | Q3 2024 · Jan 31, 2024 | $5.37M |
| Cash And Equivalents | Q3 2024 · Apr 30, 2023 | $4.94M |
| Current Liabilities | Q3 2024 · Jan 31, 2024 | $3.82M |
| Current Liabilities | Q3 2024 · Apr 30, 2023 | $3.58M |
| Total Liabilities | Q3 2024 · Jan 31, 2024 | $6.36M |
| Total Liabilities | Q3 2024 · Apr 30, 2023 | $5.3M |
| Current Assets | Q3 2024 · Jan 31, 2024 | $55.68M |
| Current Assets | Q3 2024 · Apr 30, 2023 | $52.37M |
| Total Assets | Q3 2024 · Jan 31, 2024 | $59.07M |
| Total Assets | Q3 2024 · Apr 30, 2023 | $55.95M |
| Shares Diluted | Q3 2024 · Jan 31, 2023 | 4.95M sh |
| Shares Diluted | Q3 2024 · Jan 31, 2023 | 4.95M sh |
| Dividends Paid | Q3 2024 · Jan 31, 2023 | $2.69M |
| Capex | Q3 2024 · Jan 31, 2023 | $221K |
| Operating Cash Flow | Q3 2024 · Jan 31, 2023 | $2.73M |
| Stockholders Equity | Q3 2024 · Jan 31, 2023 | $49.58M |
| Stockholders Equity | Q3 2024 · Oct 31, 2022 | $47.45M |
| Stockholders Equity | Q3 2024 · Apr 30, 2022 | $49.04M |
| Eps Diluted | Q3 2024 · Jan 31, 2023 | $0.41 |
| Eps Diluted | Q3 2024 · Jan 31, 2023 | $0.74 |
| Eps Basic | Q3 2024 · Jan 31, 2023 | $0.41 |
| Eps Basic | Q3 2024 · Jan 31, 2023 | $0.74 |
| Sga Expense | Q3 2024 · Jan 31, 2023 | $340K |
| Sga Expense | Q3 2024 · Jan 31, 2023 | $1.03M |
| Net Income | Q3 2024 · Jan 31, 2023 | $2.01M |
| Net Income | Q3 2024 · Jan 31, 2023 | $3.67M |
| Operating Income | Q3 2024 · Jan 31, 2023 | $900K |
| Operating Income | Q3 2024 · Jan 31, 2023 | $3.88M |
| Gross Profit | Q3 2024 · Jan 31, 2023 | $1.92M |
| Gross Profit | Q3 2024 · Jan 31, 2023 | $7.12M |
| Cost Of Revenue | Q3 2024 · Jan 31, 2023 | $2.44M |
| Cost Of Revenue | Q3 2024 · Jan 31, 2023 | $8.08M |
| Revenue | Q3 2024 · Jan 31, 2023 | $4.37M |
| Revenue | Q3 2024 · Jan 31, 2023 | $15.19M |